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 Various frailty screening tools have been developed. However, there is currently no single ideal model; some scores are 
better for population-level, whereas others are best suited for clinical screening and preoperative assessment. Therefore, 
the choice of the score might relay on specific clinical condition, the aim of the tool and department resources. The G8 
and the aCGA seem to be the the most suitable in the case of preoperative frailty assessments of older patients with solid 
abdominal cancer who are undergoing high-risk surgery. They also may be used to identify patients at risk for adverse 
postoperative outcomes. They may support the decision process particularly in situations of lack of experience in full 
Geriatric Assessment (easy to master and implement), in acute admitted patients (time pressure or some of the domains 
cannot be assessed) and in case of low-/moderate-risk surgery (where extensive frailty evaluation may not influence the 
postoperative outcome). 
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As was mentioned in the previous paper, the routine format 
of current preoperative requirements do not provide the in-
formation needed for optimal, tailored treatment of older 
patients with cancer. Therefore, Geriatric Assessment (GA) 
was introduced which allows for an initial assessment of the 
patient’s condition, the identification of previously unknown 
health problems, a diagnosis of frailty, and an assessment of the 
likelihood of complications [1]. However, GA requires experien-
ce, it is time-consuming (although the additional 40 minutes 
during the preoperative assessment seems to be a small price 
to pay to decrease perioperative morbidity) and not necessary 
in all patients [2, 3]. Therefore, various screening tools for frailty 
have been developed. The Vulnerable Elderly Survey (VES-13) 
[4], Triage Risk Screening Tool (TRST) [5], Geriatric 8 (G8) [6], 
Groningen Frailty Index (GFI) [7], abbreviated Comprehensive 
Geriatric Assessment (aCGA) [8], Rockwood [9], Balducci [10], 
and Fried [11] screening scores are commonly used. Table I 
presents the glossary of the above-mentioned tests, including 
the number of questions, rang and literature cut-off scores for 
a patient to be considered frail.
In 2015, an update on the International Society of Geria-
tric Oncology (SIOG) recommendations on the use of frailty 
screening tools was published [12]. In the review, the most 
common studied tools in older patients with cancer were the 
VES-13, the TRST and the G8. The highest results were obse-
rved for: G8 (median sensitivity and specificity was 77–92% 
and 39–75%, respectively), Balducci (94% and 50%) and TRST 
(91% and 47%). In our recently published paper, the G8 had 
the highest sensitivity and negative predictive value in frailty 
screening among patients with cancer undergoing high-risk 
abdominal surgery. In turn, the aCGA had the highest discrimi-
natory ability in terms of frailty screening in this population [13]. 
Most of the mentioned screening tests (VES-13, TRST, GFI, 
Rockwood, Balducci, Fried criteria) were developed based on older 
general populations. Only the G8 and the aCGA were designed 
specifically for older oncology patients [4–11]. One of the most 
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important characteristics of a screening tool is its ability to exclude 
the possibility of vulnerability, which is equivalent to a negative 
predictive value. Most of the papers regarding this topic present 
the G8 as a score meeting these conditions. In turn, its low specifi-
city may result from the fact that it was not designed to specifically 
detect an abnormal GA. Thus, the aCGA, which does derive from 
the GA, may achieve the highest overall accuracy. The VES-13 and 
Fried criteria assess mainly functional status and do not identify 
impairments in other geriatric domains such as nutritional status, 
mood, or cognitive level. The TRST was designed for the screening 
of frailty in the emergency department but various authors have 
used it also in other settings [5]. 
To conclude, there is currently no single perfect frailty-scre-
ening tool; some scores are better for population-level, where-
as others are best suited for clinical screening and preoperative 
assessment. Therefore, the choice of the score might relay on 
specific clinical conditions, the aim of the tool and department 
resources [14]. In the case of preoperative assessment of older 
patients with solid abdominal cancer, the G8 and the aCGA 
seems the most suitable [13].
The screening tests were not originally designed to predict 
the postoperative course, however, they are being increasin-
gly studied as outcome predictors. Biganzoli et al.  assessed 
patients with early-stage solid cancers using the Balducci, the 
Fried and the VES-13 score. The VES-13 score of ≥7 was a va-
luable discriminating tool for predicting functional decline or 
death. However, the authors used a higher cut-off level (≥7) 
in comparison to most publications (≥3) [15]. Bongue et al. 
evaluated the predictive performance of four frailty screening 
methods (aCGA, GFI, VES-13 and Fried score) and their AUC in 
predicting mortality ranged from 0.63 to 0.75. The tool with the 
greatest sensitivity for predicting the occurrence of disability, 
mortality and institutionalisation was the VES-13 [16]. In turn, 
Hall D et al. showed the clinical usefulness of the screening 
tool implemented in the preoperative decision process of 9153 
patients undergoing various surgical procedures. On that basis, 
physicians decided to perform detailed evaluations of the pa-
tients and to modify their perioperative plans accordingly. As a 
result the mortality rate decreased significantly 30, 180 and 365 
days after the surgery [17]. In turn, Huisman M.G. et al. analysing 
patients undergoing surgery for various solid tumours did not 
observe any significant predictive ability of the VES-13 and the 
GFI for the 30-day postoperative outcome [18].
Concluding, frailty-screening tools can be very beneficial 
in a variety of surgical fields. They can identify patients at risk 
of frailty and for adverse outcomes, particularly in situations 
of lack of experience in full GA (they are easy to master and 
implement), in acute admitted patients (when there is not 
enough time or some of the domains cannot be assessed) 
and in cases of low-/moderate-risk surgery (where extensive 
frailty evaluation may not influence the postoperative outco-
me). However, only a full Geriatric Assessment allows for: an 
appropriate preoperative evaluation (currently also the refe-
rence method for frailty diagnosis), identifying the age-related 
areas of vulnerability that can be missed in a routine clinical 
evaluation and enabling their preoperative modification. It 
also thoroughly supports the process of shared preoperative 
decision-making. In this age group the treatment goal is not 
only extension of life, but more importantly, a return to the pre-
operative functional and intellectual level in the postoperative 
period. Arguments raised about the time-consuming nature 
of this process are absurd, particularly when one considers the 
time and resources required to treat complications. Therefore, 
the use of the GA prior to high-risk surgery for all older patients 
with cancer should be recommended. 
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Table I. Glossary of the different screening tests used in the study
Test Developed for Number of items range Cut-off score*
VES-13 [4] general older population 13 0–15 ≥3
TRST [5] older patients at ED 6 0–6 ≥1
G8 [6] oncology patients 8 0–17 ≤14
GFI [7] general older population 15 0–15 ≥4









Rockwood [9] general older population 4 0–3 ≥2
Balducci [10] general older population 4 0–4 1
Fried score [11] general older population 5 0–5 ≥3
VES-13 – Vulnerable Elders Survey, TRST – Triage Risk Screening Tool, G8 – Geriatric 8, GFI – Groningen Frailty Index, aCGA – abbreviated Comprehensive Geriatric Assessment,  
ED – Emergency Department, *Cut-off score for a patient to be considered frail
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